Biblio
Export 2657 results:
Author Title [ Type
Filters: First Letter Of Last Name is S [Clear All Filters]
“The Savvy Caregiver Program: A Probe Multicenter Randomized Controlled Pilot Trial in Caregivers of Patients Affected by Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1235-1246, 2016.
, “Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.”, J Alzheimers Dis, vol. 89, no. 2, pp. 605-622, 2022.
, “Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.”, J Alzheimers Dis, vol. 87, no. 1, pp. 101-129, 2022.
, “Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.”, J Alzheimers Dis, vol. 51, no. 1, pp. 15-9, 2016.
, “S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.”, J Alzheimers Dis, vol. 64, no. 1, pp. 171-179, 2018.
, “Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis.”, J Alzheimers Dis, vol. 59, no. 3, pp. 785-795, 2017.
, “The Role of the Gut Microbiota in the Metabolism of Polyphenols as Characterized by Gnotobiotic Mice.”, J Alzheimers Dis, vol. 63, no. 2, pp. 409-421, 2018.
, “Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1235-1247, 2017.
, “Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1235-1247, 2017.
, “Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1235-1247, 2017.
, “Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1235-1247, 2017.
, “The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.”, J Alzheimers Dis, vol. 55, no. 1, pp. 183-197, 2017.
, “Role of Niemann-Pick Type C Disease Mutations in Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1249-1259, 2017.
, “The Role of Microglia in Sporadic Alzheimer's Disease.”, J Alzheimers Dis, vol. 79, no. 3, pp. 961-968, 2021.
, “The Role of Interferon-α in Neurodegenerative Diseases: A Systematic Review.”, J Alzheimers Dis, vol. 94, no. s1, pp. S45-S66, 2023.
, “The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 2, pp. 753-775, 2024.
, “Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 62, no. 3, pp. 913-932, 2018.
, “Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 62, no. 3, pp. 913-932, 2018.
, “The Role of Cognitive Reserve in Alzheimer's Disease and Aging: A Multi-Modal Imaging Review.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1341-1362, 2018.
, “The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 381-389, 2017.
, “The Role of Cerebrovascular Disease in Amyloid Deposition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1015-1026, 2016.
, “The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.”, J Alzheimers Dis, vol. 53, no. 2, pp. 373-92, 2016.
, “The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1039-1049, 2022.
, “The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 531-45, 2016.
, “The Role of ADAM10 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 2, pp. 303-322, 2017.
,